Skip to main content
Signal8
Juda Scott profile photo

Scott Juda

CIK: 0001767084

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (5.0%)

Derivative conversions

Awards (A)10 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)9 (45.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Inmune Bio, Inc. logo
INMB

Inmune Bio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (20 total)

  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Jul 2, 2026
    In-the-Money(X)

    Common Stock Purchase Warrant

    Direct
    14.8K shares at avg. $0.13-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Jul 2, 2026
    Exercise(M)
    Direct
    14.8K shares at avg. $1.40$21K
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Dec 1, 2025
    Award(A)

    Option (right to buy)

    Direct
    150K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Disposition(D)

    Stock Option (right to buy)

    Direct
    108K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    108K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Disposition(D)

    Stock Option (right to buy)

    Direct
    16K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    16K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Disposition(D)

    Stock Option (right to buy)

    Direct
    19K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    19K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Disposition(D)

    Stock Option (right to buy)

    Direct
    35K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    35K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Disposition(D)

    Stock Option (right to buy)

    Direct
    35K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    35K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Disposition(D)

    Stock Option (right to buy)

    Direct
    32.5K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    32.5K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Disposition(D)

    Stock Option (right to buy)

    Direct
    12.5K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    12.5K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Disposition(D)

    Stock Option (right to buy)

    Direct
    108K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Nov 18, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    108K shares-
  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Dec 5, 2024
    Award(A)

    Option (right to buy)

    Direct
    32.5K shares-

1-20 of 20

About Juda Scott

Juda Scott (SEC CIK 0001767084) files insider reports with the SEC as Director of Inmune Bio, Inc. (INMB).

Signal8 holds 4 ownership filings by Juda Scott, all Form 4s, filed between Dec 9, 2024 and Jul 7, 2026. Those filings report 20 transactions, from Dec 5, 2024 to Jul 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Juda Scott's filings is in BOCA RATON, FL.

Recent filings by Juda Scott

  • Jul 2, 2026: Option exercise of INMB derivative securities (Form 4, code X).
  • Jul 2, 2026: Option exercise of INMB shares (Form 4, code M).
  • Dec 1, 2025: Grant or award of INMB derivative securities (Form 4, code A).
  • Nov 18, 2025: Disposition to issuer transaction of INMB derivative securities (Form 4, code D).
  • Nov 18, 2025: Grant or award of INMB derivative securities (Form 4, code A).

Other insiders filing for Inmune Bio, Inc. (INMB)

How to read Form 4 transaction codes